Yazan Abou-Ismail Have Been Selected for the Legacy Award at the 30th Anniversary of the Qatar Foundation
Yazan Abou-Ismail, Associate Professor of Hematology at University of Utah, shared a post on LinkedIn:
“What a true honor it is to be recognized by Her Excellency Sheikha Hind bint Hamad Al-Thani, at the 30th anniversary of the Qatar Foundation, and by Her Highness Sheikha Moza bint Nasser previously in Doha. I am truly humbled to have been selected from among 278 nominations for the Legacy Award among such distinguished guests and alumni.
The real legacy is QF’s remarkable journey of transforming education, driving innovation, and investing in human potential. The QF alumni carry remarkable stories of success worldwide, and I’m grateful to be a small part of this extraordinary legacy. Thank you again to the QF and its leadership for this honor and for such a wonderful night. So great to reconnect with QF Alumni Program and Weill Cornell Medicine – Qatar WCMQ Alumni Affairs Office.”
Discover the latest in Hemostasis Today.
-
Aug 15, 2026, 19:30José Luis Neyro: E4 and DRSP Reduce Hirsutism While Showing Comparable Effects on Thrombin Generation
-
Aug 15, 2026, 19:27Mahmoud Akraym: Don’t Choose Anticoagulation as the Immediate Treatment for Unstable AF
-
Aug 15, 2026, 19:25Ahmed Bennis: DOACs Increase 1-Year Stroke Risk but Reduce MI Risk Compared With Warfarin
-
Aug 15, 2026, 19:24Megan Adediran: An Unwavering Fight for People Living With Haemophilia
-
Aug 15, 2026, 19:23Intravenous Anticoagulation Linked to Worse Early Outcomes After Noncardioembolic Stroke – International Journal of Stroke
-
Aug 15, 2026, 18:03Alejandro González Veliz: Pulmonary Embolism Is Not Always an Anticoagulation-Only Problem
-
Aug 15, 2026, 17:57Ayesha Zia: A New Foundation for Pediatric Pulmonary Embolism Research and Care
-
Aug 15, 2026, 17:50Muhammad Shaheer Bin Faheem: 25 Years of Thromboembolism and Hypertension Mortality
-
Aug 15, 2026, 17:21Bilal Salman։ NETosis as a Therapeutic Target in Inflammation and Thrombosis